| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |